Tag: Myriad Genetics

December 31, 2019

Myriad Gets FDA Approval for Metastatic Pancreatic Cancer Drug

The FDA has approved its diagnostic test to identify patients with metastatic pancreatic cancer who are candidates Lynparza treatment.
August 18, 2019

5 Top Weekly NASDAQ Biotech and Pharma Stocks: Novavax Up 82 Percent

Which biotech and pharma stocks were on the rise last week? We list the top gainers and what may have...
August 14, 2019

Myriad Genetics Tumbles on Fiscal Q4 and 2019 Results

Shares of Myriad Genetics dropped over 40 percent following the release of its latest quarterly and annual fiscal results.
July 22, 2019

What is Genetics Investing?

Genetics investing drives research that may ultimately prevent major illnesses. That makes it one of the most important life science...
June 26, 2019

6 Top Genetic Testing Stocks

Looking to invest in genetic testing? Or learn more about the companies involved? Here are six genetic testing stocks to...
May 27, 2019

7 Largest Genetics Stocks by Market Cap

The genetics industry provides data that life science companies need to make new products. Here's a look at the largest genetics...
April 9, 2019

Myriad Genetics Submits First Module of Premarket Approval Application to FDA for myChoice® HRD CDx Test

Myriad Genetics (NASDAQ:MYGN) has announced it has submitted the first module of its premarket approval (PMA) application to the US...